Colony Family Offices’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3M Buy
512,289
+25,190
+5% +$1.01M 4.69% 7
2026
Q1
$17.7M Buy
487,099
+35,746
+8% +$1.37M 4.35% 8
2025
Q4
$17.4M Buy
451,353
+38,587
+9% +$1.45M 4.33% 8
2025
Q3
$15M Sell
412,766
-98,910
-19% -$3.45M 3.88% 8
2025
Q2
$17.5M Sell
511,676
-51,813
-9% -$1.64M 4.53% 7
2025
Q1
$17.6M Buy
563,489
+313,875
+126% +$10.2M 5.5% 5
2024
Q4
$7.98M Buy
249,614
+30,223
+14% +$982K 2.51% 9
2024
Q3
$7.17M Buy
219,391
+99,112
+82% +$3.12M 2.22% 11
2024
Q2
$3.74M Buy
120,279
+52,797
+78% +$1.57M 1.2% 15
2024
Q1
$2.01M Buy
67,482
+46,819
+227% +$1.33M 0.65% 26
2023
Q4
$550K Buy
+20,663
New +$537K 0.19% 44

Other funds holding QLTY

Colony Family Offices's QLTY Position: Q2 2026 in Review

Colony Family Offices increased its GMO US Quality ETF (QLTY) stake by 5.2% in Q2 2026, buying an estimated $1.01M and bringing the position to 512,289 shares worth $21.3M. The position accounts for 4.69% of the portfolio, ranked #7.

Colony Family Offices first reported a position in QLTY in Q4 2023 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Colony Family Offices held 512,289 shares of GMO US Quality ETF worth $21.3M as of Q2 2026.
  • Colony Family Offices bought 25,190 GMO US Quality ETF shares in Q2 2026, an estimated $1.01M.
  • GMO US Quality ETF made up 4.69% of Colony Family Offices's portfolio in Q2 2026, its #7 holding.
  • Colony Family Offices first reported a position in GMO US Quality ETF in Q4 2023 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Colony Family Offices's 13F filing for Q2 2026, filed 20 Jul 2026.